You are here

Sanofi

GSK snags long-time Sanofi exec to lead vaccine and infectious disease R&D

Fierce Biotech

Mon, 06/9/25 - 11:19 am

infectious diseases

Sanjay Gurunathan

Sanofi starts shipping RSV drug early as rival nears market

Pharmaphorum

Mon, 06/9/25 - 10:53 am

Vigil's rare brain disease drug flunks phase 2 study, but Sanofi takeover is unaffected

Fierce Biotech

Wed, 06/4/25 - 11:06 am

Vigil Neuroscience

clinical trials

ASCO: Sanofi shows investigational Sarclisa SC, delivered by on-body device, measures up to its IV formulation

Fierce Pharma

Tue, 06/3/25 - 11:39 am

Multiple Myeloma

Sanofi expands rare immunology portfolio with Blueprint buyout

Yahoo/Benzinga

Mon, 06/2/25 - 11:33 am

Blueprint Medicines

Mixed COPD results for Regeneron, Sanofi drug cloud approval chances

BioPharma Dive

Fri, 05/30/25 - 11:23 am

clinical trials

FDA approves use of Sanofi's meningococcal vaccine in infants

MSN/Reuters

Wed, 05/28/25 - 09:52 am

meningococcal disease

Sanofi admits giving free Olympics tickets to patients

Pharmaphorum

Tue, 05/27/25 - 11:04 am

Sanofi opens doors to $130M 'flagship' US office facility in New Jersey

Fierce Pharma

Thu, 05/22/25 - 09:22 pm

Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race

Fierce Biotech

Thu, 05/22/25 - 11:42 am

Vigil Neuroscience

Alzheimer's disease

Zentiva inks €220M deal to commercialize AstraZeneca GI cast-off in Europe

Fierce Pharma

Thu, 05/22/25 - 11:10 am

linaprazan glurate

Sanofi hops on the US investment bandwagon with $20B commitment through 2030

Fierce Pharma

Wed, 05/14/25 - 10:52 pm

drug manufacturing

Sanofi axes IGM pact, sparking 80% layoffs at the biotech and facility closures

Fierce Biotech

Fri, 05/9/25 - 08:28 am

IGM Biosciences

Sanofi exec tells biotechs not to scrimp on clinical trial design

Clinical Trials Arena

Thu, 05/8/25 - 10:47 pm

clinical trials

clinical trial design

Sanofi nets €10B from Opella stake sale, eyes more 'bolt-on' deals

Fierce Pharma

Wed, 04/30/25 - 11:47 pm

consumer health

Sanofi's quarterly profit boosted by Dupixent and newer drugs; forecast unchanged

MSN Reuters

Thu, 04/24/25 - 11:01 am

Sanofi hands back cancer NK cell engager to Innate amid autoimmune pivot

Fierce Biotech

Wed, 04/23/25 - 09:47 am

natural killer cells

Sanofi, Regeneron win FDA nod for Dupixent in chronic hives

BioPharma Dive

Mon, 04/21/25 - 11:13 am

Sanofi pens $1.8B research deal for 2 bispecific antibodies aimed at autoimmune, immunology

Fierce Biotech

Thu, 04/17/25 - 11:08 am

bispecific antibodies

ulcerative colitis

Crohn’s disease

Sanofi's 'daughter of Dupixent' heads to phase 3 in asthma

Pharmaphorum

Tue, 04/15/25 - 09:53 am

clinical trials

Pages